slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 44,971-45,000
Pages 2,019
Rows per page 30
Component
44,971-45,000 of 60,568
29
The slide uses a matrix-like structure to compare NVL-520's clinical profile against five competitors (Crizotinib, Entrectinib, Lorlatinib, Repotrectinib, Taletrectinib).Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
31
The slide presents a summary of a clinical trial, including patient eligibility criteria and a breakdown of patient cohorts by dose level.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
33
Includes a summary table of ORR and a waterfall plot of tumor regression.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
35
Data as of 13 Sep 2022. Includes list of specific adverse events by grade.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
38
The slide outlines a multi-cohort study design with specific patient populations (TKI-naive vs pre-treated) and objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
13
Includes footnotes defining backlog and long-term backlog criteria.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
14
Includes footnotes explaining specific revenue components.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
15
Omnicell | Investor Presentation Deck | 27 slidesOmnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
16
Includes a disclaimer regarding non-GAAP reconciliation and a definition of bookings.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
22
Includes footnotes (a) and (b) explaining specific impairment and litigation costs.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
23
Includes footnotes (a), (b), and (c) detailing specific adjustments.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
25
The table includes specific line items for non-GAAP adjustments such as share-based compensation, interest, depreciation, and various one-time costs.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
26
Includes a footnote defining the Net Debt/EBITDA calculation.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
08
Orbia | Results Presentation Deck | 10 slidesOrbia | Results Presentation Deck | 10 slides · Orbia
Conference presentation Investor relations Beat · Action1 hit
09
The slide showcases four specific medical device products categorized into two therapy types.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Solution1 hit
21
Includes detailed line-item adjustments for non-GAAP financial measures.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations 1 hit
22
Includes reconciliation of non-GAAP financial measures related to the merger.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations 1 hit
16
The chart highlights the acquisition of Crestmark in 2018 as a key inflection point in loan balance growth.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
19
Standard financial disclosure slide for non-GAAP metrics.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
05
Pershing Square | Investor Presentation Deck | 59 slidesPershing Square | Investor Presentation Deck | 59 slides · Pershing Square Holdings
Conference presentation Investor relations Beat · Interest1 hit
08
The slide uses a clear comparative table structure to highlight outperformance. Includes specific footnotes for index definitions and data limitations.Pershing Square | Investor Presentation Deck | 59 slides · Pershing Square Holdings
Conference presentation Investor relations Beat · Interest1 hit
19
The chart uses a dashed line to visually separate the primary subject (PSH NAV) from the benchmark indices.Pershing Square | Investor Presentation Deck | 59 slides · Pershing Square Holdings
Conference presentation Investor relations Beat · ActionLoop · So What Cascade1 hit
20
The table distinguishes between PSLP (unlevered) and PSH (modestly levered) fee structures and performance periods.Pershing Square | Investor Presentation Deck | 59 slides · Pershing Square Holdings
Conference presentation Investor relations Beat · ActionLoop · So What Cascade1 hit
22
The slide includes a specific callout box referencing a 2018 investor presentation, marking a pivot point in the performance trajectory.Pershing Square | Investor Presentation Deck | 59 slides · Pershing Square Holdings
Conference presentation Investor relations Beat · ActionLoop · So What Cascade1 hit
24
The table includes a total row and a footnote regarding the calculation of net contributors.Pershing Square | Investor Presentation Deck | 59 slides · Pershing Square Holdings
Conference presentation Investor relations Beat · ActionLoop · So What Cascade1 hit
25
The table breaks down performance detractors by category, including underlying portfolio positions and bond interest expense.Pershing Square | Investor Presentation Deck | 59 slides · Pershing Square Holdings
Conference presentation Investor relations Beat · ActionLoop · So What Cascade1 hit
26
The table breaks down AUM into Total and Equity, and Insider Capital into Total and percentage of Equity.Pershing Square | Investor Presentation Deck | 59 slides · Pershing Square Holdings
Conference presentation Investor relations Beat · ActionLoop · So What Cascade1 hit
35
Pershing Square | Investor Presentation Deck | 59 slidesPershing Square | Investor Presentation Deck | 59 slides · Pershing Square Holdings
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
09
Includes adjustments for share-based compensation, amortization, and other expenses.Pinterest | Results Presentation Deck | 13 slides · Pinterest
Conference presentation Investor relations 1 hit
10
Includes adjustments for share-based compensation, amortization, and other expenses.Pinterest | Results Presentation Deck | 13 slides · Pinterest
Conference presentation Investor relations 1 hit